Markets:

Overview

News

Currencies

International

Treasuries

Organogenesis Holdings Inc. - Class A (NQ:ORGO)

1.320 -0.020 (-1.49%)

Delayed Quote Updated: 4:00 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Organogenesis Holdings Inc. - Class A

< Previous 1 2 3 4 5 6 Next >

Organogenesis (ORGO) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

CMS policy changes drove 58% revenue decline, but sequential recovery signals stabilization.

Via The Motley Fool

Topics Earnings

What's going on in today's session ↗

August 07, 2026

Via Chartmill

Which stocks are gapping on Friday? ↗

August 07, 2026

Via Chartmill

Top movers in Friday's pre-market session ↗

August 07, 2026

Via Chartmill

Organogenesis Holdings (NASDAQ:ORGO) Plunges 17% as Q2 Revenue and EPS Miss Estimates ↗

August 06, 2026

Via Chartmill

Organogenesis Holdings Inc (NASDAQ:ORGO) Soars on Stellar Q4 Earnings Beat ↗

February 26, 2026

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Organogenesis Q2 Earnings Call Highlights ↗

August 07, 2026

Organogenesis (NASDAQ:ORGO) reported a sharp year-over-year decline in second-quarter revenue as the skin substitute market continued to adjust to coverage and payment changes from the Centers for...

Via MarketBeat

Topics Earnings

Organogenesis (ORGO) Q1 2026 Earnings Transcript ↗

May 08, 2026

Organogenesis (ORGO) Q1 2026 Earnings Transcript

Via The Motley Fool

Organogenesis Q1 Earnings Call Highlights ↗

May 08, 2026

Organogenesis (NASDAQ:ORGO) reported a sharp year-over-year revenue decline in the first quarter of 2026, with executives pointing to significant disruption in the skin substitute market following...

Via MarketBeat

Topics Earnings

Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis Widens

April 13, 2026

CANTON, Mass. — In a milestone development for the regenerative medicine sector, Organogenesis Holdings Inc. (Nasdaq: ORGO) announced today that it has successfully concluded a pivotal Type B meeting...

Via MarketMinute

Organogenesis (ORGO) Q4 2025 Earnings Transcript ↗

February 26, 2026

Organogenesis (ORGO) Q4 2025 Earnings Transcript

Via The Motley Fool

Get insights into the top gainers and losers of Monday's after-hours session. ↗

December 15, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Unusual volume stocks in Monday's session ↗

November 10, 2025

Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.

Via Chartmill

What's going on in today's session ↗

November 07, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Keep an eye on the top gainers and losers in Friday's session. ↗

November 07, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 07, 2025

Via Benzinga

These stocks are gapping in today's session ↗

November 07, 2025

The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 07, 2025

Via Benzinga

Sanara MedTech Inc. Navigates Market Downturn Amidst "Undervalued" Consensus and Strategic Shifts

October 17, 2025

Dallas, TX – October 17, 2025 – Sanara MedTech Inc. (NASDAQ: SMTI), a company focused on surgical and chronic wound care, finds itself in the spotlight today as a bottom market performer, with its...

Via MarketMinute

Organogenesis Holdings (ORGO) Battles Headwinds: Can This Regenerative Medicine Innovator Stage a Comeback?

October 17, 2025

Canton, MA – Organogenesis Holdings Inc. (NASDAQ: ORGO), a prominent player in the regenerative medicine sector, has recently endured a period of significant stock weakness, leaving investors...

Via MarketMinute

Topics Fraud

Why Is Organogenesis Stock Trading Lower Friday? ↗

September 26, 2025

Organogenesis Holdings Inc. (NASDAQ: ORGO) shared topline data on Thursday from the second Phase 3 randomized controlled trial (RCT) of ReNu, a cryopreserved amniotic suspension allograft (ASA) for the...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 26, 2025

Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 25, 2025

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their outstanding shares is at $5.6 million.

Via Benzinga

ORGO Sales Drop 23% ↗

August 07, 2025

Via The Motley Fool

Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 15, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

July 15, 2025

Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 15, 2025

Via Benzinga

Why Trade Desk Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗

July 15, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.